JPH04154719A - Athlete's foot drug - Google Patents

Athlete's foot drug

Info

Publication number
JPH04154719A
JPH04154719A JP2279165A JP27916590A JPH04154719A JP H04154719 A JPH04154719 A JP H04154719A JP 2279165 A JP2279165 A JP 2279165A JP 27916590 A JP27916590 A JP 27916590A JP H04154719 A JPH04154719 A JP H04154719A
Authority
JP
Japan
Prior art keywords
athlete
foot
therapeutic agent
thymol
menthol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2279165A
Other languages
Japanese (ja)
Inventor
Hiroshi Kikuchi
寛 菊池
Takeshi Kikuchi
健 菊池
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2279165A priority Critical patent/JPH04154719A/en
Publication of JPH04154719A publication Critical patent/JPH04154719A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a therapeutic agent of athlete's foot containing methyl salicylate, l-menthol, dl-camphor, chlorpheniramine maleate, thymol, nonylic acid vanillylamide, pyrethrum powder and a squeezed solution of aloe. CONSTITUTION:An amount of 6000mg of methyl salicylate is mixed in 380-400ml acetic acid together with 6240mg of l-menthol, 6240mg of dl-camphor, 120mg of chlorpheniramine maleate, 840mg of thymol, 12mg of nonylic acid vanillylamide, 14g of pyrethrum dried powder and a squeezed solution of a piece of aloe leaf and stirred to prepare a therapeutic agent of athlete's foot. Said therapeutic agent is preferably exposed to sunshine for about 60hr. When it is used, washing of lesion with hot or cold water improves curing effect thereof. Next, the lesion is repeatedly dipped in vinegar warmed to a temp. of generating steam and said therapeutic agent is applied, thus capable of enhancing the therapeutic effect. This process is repeated daily twice.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、いわゆる水虫(汗庖状白癖)の治療に用いる
薬に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a drug used for the treatment of so-called athlete's foot (alcoholism).

[従来の技術]及び [発明が解決しようとする課題] 従来、水虫治療薬は多種製造されてきたが、いずれも水
虫を完全に治療することができるものではなかった。か
かる従来の水虫治療薬の寅情を鑑みて、本発明はなされ
たものであり、より完璧に水虫を治療するための新たな
薬を提供することが本発明の目的である。
[Prior Art] and [Problems to be Solved by the Invention] Conventionally, various drugs for treating athlete's foot have been produced, but none of them can completely treat athlete's foot. The present invention was made in view of the current situation with conventional drugs for treating athlete's foot, and an object of the present invention is to provide a new drug for more completely treating athlete's foot.

[課題を解決するための手段] 上記目的は、請求項に記載された水虫薬、すなわち、 サルチル酸メチル      6000mg。[Means to solve the problem] The above object is achieved by the athlete's foot medicine as defined in the claims, namely: Methyl salicylate 6000mg.

i−メントール       6240mg、d2−カ
ンフル       6240mg、マレイン酸クロル
フェニラミン 120mg、チモール        
   840mg。
i-menthol 6240mg, d2-camphor 6240mg, chlorpheniramine maleate 120mg, thymol
840mg.

ノニル酸ワニリルアミド     、12mgと除虫菊
乾燥粉末14gを酢酸380〜400mβ中に混合し、
さらにアロエの葉1枚分の絞り汁を加えてなる水虫薬に
よって、達成される。
12 mg of nonylic acid vanillylamide and 14 g of dried pyrethrum powder were mixed in 380-400 mβ of acetic acid,
This can also be achieved by using an athlete's foot medicine made by adding the juice of one aloe leaf.

[実施例] 酢酸380mtl中に、サルチル酸メチル6000mg
、 12−ylントール6240mg、 d42−カン
ル6240mg、マレイン酸りロルフェニラミ120m
g、チモール840mg、ノニル酸ワニルアミト12m
gを加え、良く攪拌、混合し、そ2に除虫菊乾燥粉末1
4gを投入、撹拌して混合−る、さらにアロエの葉1枚
分の絞り汁を加えて、ノ発明の水虫薬を得る。好ましく
は、この水虫薬を岸60時間太陽光線に当てると良い。
[Example] 6000 mg of methyl salicylate in 380 ml of acetic acid
, 12-yl nthol 6240mg, d42-kanru 6240mg, maleic acid lorphenirami 120m
g, thymol 840mg, nonylic acid vanillamide 12m
Add 1 g of pyrethrum dry powder and stir well to mix.
Add 4g of the mixture, stir to mix, and add the juice of one aloe leaf to obtain the athlete's foot medicine of the invention. Preferably, this athlete's foot medicine should be exposed to sunlight for 60 hours.

水虫薬を付ける前には2湯または水をもって、h部を洗
うと治療効果が向上する0次いで、湯気がdる程度に暖
めた酢を洗面器等の答器に溜め、患部(十分に酢に浸す
ことを数回繰り返す、その後に、Δ発明の水虫薬を付け
ると、水虫の治療効果が高くξる。かかる用法で、毎日
2回、朝と晩に行い、約1ケ月続けると、著しく水虫が
治る。なお、この治嗣の期間は、石鹸を患部にけっして
付けないように8意しなければならない。
Before applying athlete's foot medicine, wash the affected area with hot water or cold water to improve the treatment effect. If you repeat soaking in water several times and then apply the athlete's foot medicine invented by Δ, the treatment effect for athlete's foot is highly ξ.If you use this method twice a day, in the morning and evening, for about a month, you will notice a noticeable effect. Athlete's foot will be cured. During this period of treatment, you must refrain from applying soap to the affected area.

この水虫薬の作用原理は現在のところ明らかでローない
が、乾性の水虫患者50名に上記の用法で本磐明の水虫
薬を用いたところ約40名が治り、また、7   p性
の水虫患者30名に上記の用法で本発明の水虫ン  薬
を用いたところ約24名が治り、水虫治療の効果)  
 が大きいことがわかった。
The principle of action of this athlete's foot medicine is not clear at present, but when Akira Motowa's athlete's foot medicine was used in the above manner on 50 patients with dry athlete's foot, about 40 people were cured. When the athlete's foot drug of the present invention was used on 30 patients in the above-mentioned manner, approximately 24 patients were cured (effect of athlete's foot treatment)
was found to be large.

「 9      特許出願人  菊 池   寛ジ 〔" 9 Patent applicant Hiroji Kikuike [

Claims (1)

【特許請求の範囲】 1 サルチル酸メチル6000mg、 l−メントール6240mg、 dl−カンフル6240mg、 マレイン酸クロルフェニラミン120mg、チモール8
40mg、 ノニル酸ワニリルアミド12mgと 除虫菊乾燥粉末14gを酢酸380〜400ml中に混
合し、さらにアロエの葉1枚分の絞り汁を加えてなる水
虫薬。
[Claims] 1 6000 mg of methyl salicylate, 6240 mg of l-menthol, 6240 mg of dl-camphor, 120 mg of chlorpheniramine maleate, 8 thymol
An athlete's foot medicine prepared by mixing 12 mg of nonylic acid vanillylamide and 14 g of dried pyrethrum powder in 380 to 400 ml of acetic acid, and adding the squeezed juice of one aloe leaf.
JP2279165A 1990-10-19 1990-10-19 Athlete's foot drug Pending JPH04154719A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2279165A JPH04154719A (en) 1990-10-19 1990-10-19 Athlete's foot drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2279165A JPH04154719A (en) 1990-10-19 1990-10-19 Athlete's foot drug

Publications (1)

Publication Number Publication Date
JPH04154719A true JPH04154719A (en) 1992-05-27

Family

ID=17607359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2279165A Pending JPH04154719A (en) 1990-10-19 1990-10-19 Athlete's foot drug

Country Status (1)

Country Link
JP (1) JPH04154719A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000168A1 (en) * 1996-07-02 1998-01-08 Novartis Consumer Health S.A. Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
EP1634500A3 (en) * 1998-07-28 2006-08-09 Ecosmart Technologies Inc. Synergistic and residual pesticidal compositions containing plant essentials oils
US7250175B2 (en) 1998-07-28 2007-07-31 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
EP1779729A3 (en) * 1998-07-28 2007-09-05 EcoSmart Technologies Inc. Synergistic and residual pesticidal compositions containing plant essential oils
JP2008514596A (en) * 2004-09-24 2008-05-08 ミシガン ステイト ユニバーシティー Composition without carrier for the treatment of onychomycosis
CN103301268A (en) * 2013-06-13 2013-09-18 中国人民解放军海军总医院 Ointment for jellyfish sting and preparation method thereof
US8920864B2 (en) 2005-08-12 2014-12-30 Takasago International Corporation Sensation masking composition

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000168A1 (en) * 1996-07-02 1998-01-08 Novartis Consumer Health S.A. Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
US7476397B2 (en) 1998-07-28 2009-01-13 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7531189B2 (en) 1998-07-28 2009-05-12 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
EP1779729A3 (en) * 1998-07-28 2007-09-05 EcoSmart Technologies Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7320966B2 (en) 1998-07-28 2008-01-22 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7351420B2 (en) 1998-07-28 2008-04-01 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7361366B2 (en) 1998-07-28 2008-04-22 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7250175B2 (en) 1998-07-28 2007-07-31 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
EP1634500A3 (en) * 1998-07-28 2006-08-09 Ecosmart Technologies Inc. Synergistic and residual pesticidal compositions containing plant essentials oils
US7618645B2 (en) 1998-07-28 2009-11-17 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7534447B2 (en) 1998-07-28 2009-05-19 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
US7537777B2 (en) 1998-07-28 2009-05-26 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils
JP2008514596A (en) * 2004-09-24 2008-05-08 ミシガン ステイト ユニバーシティー Composition without carrier for the treatment of onychomycosis
US8920864B2 (en) 2005-08-12 2014-12-30 Takasago International Corporation Sensation masking composition
US9974740B2 (en) 2005-08-12 2018-05-22 Takasago International Corporation (Usa) Sensation masking composition
CN103301268A (en) * 2013-06-13 2013-09-18 中国人民解放军海军总医院 Ointment for jellyfish sting and preparation method thereof

Similar Documents

Publication Publication Date Title
US5958462A (en) Therapeutic bath salts and method of use
JPS63139136A (en) Enhancer for transdermal transmission of general medicine
CN101085300A (en) Plaster for treating hyperosteogeny and pain, and its preparation method
CN111514262B (en) Self-heating acupoint application traditional Chinese medicine composition and preparation method thereof
JPH04154719A (en) Athlete's foot drug
CA1228540A (en) Process for the preparation of antispasmatic products to be fixed on the skin, in particular for the spasm of the muscles
CN102038923A (en) Medicament for treating dandruff
WO1999003485A1 (en) External preparations containing watercress extract
CH677319A5 (en) COSMETIC PRODUCTS FOR HEALTH AND Koerperpflege OR MEDICINES.
JPH03123732A (en) Massage material
CN1035743C (en) Process of preparing tincture for curing scar
JP2002532555A (en) Use of steam ironing of fabrics as a technique for producing a reduced physiological and / or subjective response to stress in humans
US3996350A (en) Methods and compositions for alleviating fungus infections of the skin
JP2814230B2 (en) Cosmetic composition
JPH02119863A (en) Heating moxa cautery and method thereof
JPH05117140A (en) Soap mixed with garlic essence containing vitamin b1
CN110693853A (en) Traditional Chinese medicine cataplasm beneficial to promoting growth of height of children and preparation method thereof
JPS6356206B2 (en)
JPH03264517A (en) Composition for shower
CN1115246A (en) "Longfeng yishou" wine and its prepn. method
EP0807438B1 (en) Compositions for promoting health and curing bruises comprising a titanium based material
Karacostas et al. Beneficial effect of piracetam monotherapy on post-ischaemic palatal myoclonus
CN1070057C (en) External sponge bath agent for reducing fever and preparation and application thereof
CN100569229C (en) Kill the specially good effect side of dermatophytes
JPH02189152A (en) Moxa refined oil paste